Ex parte AINSLIE et al. - Page 9




          Appeal No. 1996-2991                                                         
          Application 08/302,931                                                       


               As to dependent claim 17, the recitation therein is that                
          the particular mole percentage is recited for the boron oxide                
          to be “at least 2 mole %.”  Although the boron mole % is not                 
          recited in Farries, inasmuch as the actual recited amount in                 
          dependent claim 17 is such a low value, any minor doping or                  
          any doping at all in Farries obviously would have been at                    
          least such a small amount.  Appellants have not challenged the               
          examiner's observation at the top of page 11 of the answer                   
          that it was well known in the art that normal doping would                   
          have exceeded the claimed amount and since the claim only                    
          requires the doping to be at least 2 %, we are persuaded of                  
          the obviousness of the subject matter of claim 17 on appeal.                 


               As a final matter with respect to appellants' arguments                 
          in the brief and reply brief as to this rejection, appellants                
          have presented no evidence that the boron in Farries does not                
          contribute in some manner to the formation of the gratings                   
          therein.  In any event, we are in agreement with the                         
          examiner's general observations at pages 9 and 10 of the                     
          answer in response to the appellants' arguments as to this                   
          rejection.  No matter what may be the proper characterization                
                                           9                                           





Page:  Previous  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  Next 

Last modified: November 3, 2007